Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DX25F6ABL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $51,129
Award facts
- Contract value 100% obligated
- $51,129.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $51,129.28 on July 18, 2025, for Alecensa 150 mg capsules (240-count units) under a Defense Logistics Agency contract. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a single transaction within DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The award carries no set-aside designation, demonstrating the contractor's competitive standing in federal pharmaceutical procurement.
This delivery order supports the Medical Supply Chain, a defense-focused federal agency program that distributes pharmaceutical products to Department of Defense healthcare facilities nationwide. Alecensa is an oncology medication used in cancer treatment, reflecting the breadth of specialized pharmaceutical products that DMS Pharmaceutical Group supplies to military health facilities. As a crucial supplier in the federal pharmaceutical supply chain, the contractor fulfills delivery orders for branded and generic prescription drugs, biologics, and medical consumables, ensuring continuity of critical medications across the Defense Department's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DX25F6ABL?
SPE2DX25F6ABL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 18, 2025.
How much is contract SPE2DX25F6ABL worth?
The government has obligated $51,129 on SPE2DX25F6ABL.
Is contract SPE2DX25F6ABL an order under another contract?
Yes. SPE2DX25F6ABL is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABL competed?
The extent of competition for SPE2DX25F6ABL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award